PharmaPart News

2008

January - Dr. Nafsika Kronidou heads Regulatory Affairs at PharmaPart.

PharmaPart is pleased to announce the appointment of Dr. Nafsika Kronidou to the position of Head of Regulatory Affairs. Most recently with Novartis, Dr. Kronidou has 11 years experience in the field, having brought a number of products to market through various regulatory authorities.

2007

November - Dr. Wilfried Hauke announced as the Managing Director of PharmaPart GmbH.

PharmaPart is pleased to announce the appointment of Dr. Wilfried Hauke to the position of Managing Director ( Germany ). Dr. Hauke brings a wealth of industry and management experience to the company and as such will make a considerable contribution during this period of expansion. Dr. Hauke is also a member of the General Management of PharmaPart.

November - PharmaPart completes a hepatitis C Phase III study

PharmaPart presented the results of a 52 week, multi-centre, double blind, placebo-controlled study during the AASLD in Boston Nov 2-6. Read More.

August - Dr. Donald E. McCaskey assumes the position of Clinical Operations Manager at PharmaPart AG.

PharmaPart is pleased to announce the appointment of Dr. Donald E. McCaskey to the position of Clinical Operations Manager. Dr. McCaskey brings with him a wealth of experience in all fields of the European CRO business including many years in the Eastern block.

June - PharmaPart GmbH Opens Office in Wiesbaden.

PharmaPart GmbH has officially moved offices to a new location in Wiesbaden, Germany. The offices are on the third floor of a refurbished building on what was originally the Hoechst manufacturing site.